Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2002-06-10

Original market date: See footnote 1

1994-12-31

Product name:

WYDASE INJECTION LIQ 150 UNITS/ML

DIN:

02041278 Electronic product monograph is not available

Company:

WYETH-AYERST CANADA INC.
1025 Marcel Laurin Blvd.
St. Laurent
Quebec
Canada H4R 1J6

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Block/Infiltration ,  Subcutaneous

Number of active ingredient(s):

1

Schedule(s):

Schedule D

 

American Hospital Formulary Service (AHFS): See footnote 3

44:00.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

B06AA03 HYALURONIDASE

Active ingredient group (AIG) number:See footnote5

0107586001

List of active ingredient(s)
Active ingredient(s) Strength
HYALURONIDASE 150 UNIT / ML
Version 4.0.2
Date modified: